Resultados da pesquisa

Clinical and MRI phenotype of children with MOG antibodies Por Cristina Fernandez-Carbonell, David Vargas-Lowy, Alexander Musallam, Brian C. Healy, Katherine McLaughlin, Kai W. Wucherpfennig, Tanuja Chitnis

Obter o texto integral

Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity? Por Alessandro M. F. Fernandes, André de Campos Duprat, Cláudia Alessandra Eckley, Leonardo da Silva, Roberta Busch Ferreira, Charles Peter Tilbery

Obter o texto integral

Randomized study combining interferon and glatiramer acetate in multiple sclerosis Por Fred Lublin, Stacey S. Cofield, Gary Cutter, Robin Conwit, Ponnada A. Narayana, Flavia Nelson, Amber Salter, Tarah Gustafson, Jerry S. Wolinsky

Obter o texto integral

Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis Por Fernanda Tovar‐Moll, Iordanis E. Evangelou, Annie W Chiu, Sungyoung Auh, Christina Chen, Mary Ehrmantraut, Joan Ohayon, Nancy Richert, Francesca Bagnato

Obter o texto integral

In vivo evidence of glutamate toxicity in multiple sclerosis Por Christina Azevedo, John Kornak, Philip Chu, Mehul Sampat, Darin T. Okuda, Bruce Cree, Sarah J. Nelson, Stephen L. Hauser, Daniel Pelletier

Obter o texto integral

Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis Por Daniel M. Harrison, Snehashis Roy, Jiwon Oh, Izlem Izbudak, Dzung L. Pham, Susan Courtney, Brian Caffo, Craig Jones, Peter C.M. van Zijl, Peter A. Calabresi

Obter o texto integral Obter o texto integral

Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study Por Laura Ordóñez-Boschetti, Roberto Rey, Ana Lúıza Gibertoni Cruz, Arijit Sinha, Tracy Reynolds, Nadina Frider, Regina Maria Papais Alvarenga

Obter o texto integral Obter o texto integral

Black holes in multiple sclerosis: definition, evolution, and clinical correlations Por Mohammad Ali Sahraian, Ernst W. Radue, Sven Haller, Ludwig Kappos

Obter o texto integral

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis Por The CAMMS Trial Investigators

Obter o texto integral Obter o texto integral

Multiple measures of corticospinal excitability are associated with clinical features of multiple sclerosis Por Jason L. Neva, Bimal Lakhani, Katlyn E. Brown, Katie P. Wadden, Cameron S. Mang, N.H.M. Ledwell, Michael R. Borich, Irene M. Vavasour, Cornelia Laule, Anthony Traboulsee, Alex L. MacKay, Lara A. Boyd

Obter o texto integral

Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis Por Tomáš Kalinčík, Dana Horáková, Tim Spelman, Vilija Jokubaitis, María Trojano, Alessandra Lugaresi, Guillermo Izquierdo, Csilla Rózsa, Pierre Grammond, Raed Alroughani, Pierre Duquette, Marc Girard, Eugenio Pucci, Jeannette Lechner‐Scott, Mark Slee, Ricardo Fernández‐Bolaños, F. Grand’Maison, Raymond Hupperts, Freek Verheul, Suzanne Hodgkinson, Celia Oreja‐Guevara, Daniele Spitaleri, Michael Barnett, Murat Terzi, Roberto Bergamaschi, Pamela McCombe, José Luis Sánchez-Menoyo, Magdolna Simó, Tünde Csépány, G. Rum, Cavit Boz, Eva Havrdová, Helmut Butzkueven

Obter o texto integral Obter o texto integral

In vivo imaging of spinal cord atrophy in neuroinflammatory diseases Por Winston Liu, Govind Nair, Luisa Vuolo, Anshika Bakshi, Raya Massoud, Daniel S. Reich, Steven Jacobson

Obter o texto integral

Work-related problems in multiple sclerosis: a literature review on its associates and determinants Por Alberto Raggi, Venusia Covelli, Silvia Schiavolin, Chiara Scaratti, Matilde Leonardi, Michelle Willems

Obter o texto integral

Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker Por Shannon Kolind, Arshia Seddigh, Anna Combes, Bretta Russell‐Schulz, Roger Tam, Vignan Yogendrakumar, Sean Deoni, Naomi Sibtain, Anthony Traboulsee, Steven Williams, Gareth J. Barker, Peter Brex

Obter o texto integral

Detection of postural sway abnormalities by wireless inertial sensors in minimally disabled patients with multiple sclerosis: a case–control study Por Andrew Solomon, Jesse V. Jacobs, Karen V. Lomond, Sharon M. Henry

Obter o texto integral Obter o texto integral

Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients Por Johannes Ehler, Sebastian Koball, Martin Sauer, Steffen Mitzner, Heiko Hickstein, Reiner Benecke, Uwe K. Zettl

Obter o texto integral Obter o texto integral

Quality of life and impairment in patients with multiple sclerosis Por A-K Isaksson

Obter o texto integral Obter o texto integral

Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing‐remitting multiple sclerosis Por Shibeshih Belachew, Rémy Phan-Ba, E Bartholomé, Valérie Delvaux, I. Hansen, Philippe Calay, Kaoutar El Hafsi, Gustave Moonen, Luaba Tshibanda, Mathieu Vokaer

Obter o texto integral

Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiori... Por Emmanuelle Le Page, D. Veillard, David Laplaud, Stéphanie Hamonic, R. Wardi, Christine Lebrun‐Frénay, Fabien Zagnoli, Sandrine Wiertlewski, V. Deburghgraeve, Marc Coustans, Gilles Edan

Obter o texto integral

Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositive patients in a Chinese population Por Zhifeng Mao, Junjie Yin, Xiaonan Zhong, Zhihua Zhao, Wei Qiu, Zhengqi Lu, Xueqiang Hu

Obter o texto integral Obter o texto integral